Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 166 AL 180

Promising heterocycle-based scaffolds in recent (2019-2021) anti-Alzheimer's drug design and discovery

Dorababu A.

Eur J Pharmacol. 2022 Apr 5;920:174847. doi: 10.1016/j.ejphar.2022.174847. Epub 2022 Feb 23.

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neurochem Int. 2022 May;155:105311. doi: 10.1016/j.neuint.2022.105311. Epub 2022 Feb 23.

Mitochondrial ribosomal protein genes connected with Alzheimer's and tellurite toxicity

Del Giudice L, Alifano P, Calcagnile M, Di Schiavi E, Bertapelle C, Aletta M, Pontieri P.

Mitochondrion. 2022 May;64:45-58. doi: 10.1016/j.mito.2022.02.006. Epub 2022 Feb 24.

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Islam M, Shen F, Regmi D, Du D.

Biochem Pharmacol. 2022 Apr;198:114979. doi: 10.1016/j.bcp.2022.114979. Epub 2022 Feb 24.

Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials

McManus KR, Lapid MI, Forester BP, Mueller M, Hermida AP, Nykamp L, Harper DG, Seiner SJ, Sanghani S, Patrick R, Gentry MT, Kung S, Leal JC, Johnson EK, Petrides G.

J ECT. 2022 Sep 1;38(3):165-170. doi: 10.1097/YCT.0000000000000832. Epub 2022 Mar 1.

How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?

Séguy L, Groo AC, Malzert-Fréon A.

Drug Discov Today. 2022 Jun;27(6):1575-1589. doi: 10.1016/j.drudis.2022.02.022. Epub 2022 Feb 25.

Impaired insulin signalling and allostatic load in Alzheimer disease

De Felice FG, Gonçalves RA, Ferreira ST.

Nat Rev Neurosci. 2022 Apr;23(4):215-230. doi: 10.1038/s41583-022-00558-9. Epub 2022 Feb 28.

Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers

Golde TE.

Neurotherapeutics. 2022 Jan;19(1):209-227. doi: 10.1007/s13311-022-01201-2. Epub 2022 Feb 28.

Acupuncture-related treatments improve cognitive and physical functions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Lin CJ, Yeh ML, Wu SF, Chung YC, Lee JC.

Clin Rehabil. 2022 May;36(5):609-635. doi: 10.1177/02692155221079117. Epub 2022 Mar 1.

Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality

Qin C, Wang K, Zhang L, Bai L.

Animal Model Exp Med. 2022 Feb;5(1):15-26. doi: 10.1002/ame2.12207. Epub 2022 Jan 29.

Hippocampal neurogenesis and pro-neurogenic therapies for Alzheimer's disease

Zheng J.

Animal Model Exp Med. 2022 Feb;5(1):3-14. doi: 10.1002/ame2.12212. Epub 2022 Feb 6.

Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage

Jiang YH, He JK, Li R, Chen ZH, Jia BH.

Chin J Integr Med. 2022 Mar;28(3):272-280. doi: 10.1007/s11655-022-3511-6. Epub 2022 Mar 1.

"Aducanumab" making a comeback in Alzheimer's disease: An old wine in a new bottle

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Felemban SG, Alsubayiel AM, Bhatia S, Bungau S.

Biomed Pharmacother. 2022 Apr;148:112746. doi: 10.1016/j.biopha.2022.112746. Epub 2022 Feb 26.

APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease

Parhizkar S, Holtzman DM.

Semin Immunol. 2022 Jan;59:101594. doi: 10.1016/j.smim.2022.101594. Epub 2022 Feb 26.

Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease

Saeedi M, Mehranfar F.

Recent Pat Biotechnol. 2022;16(2):102-121. doi: 10.2174/1872208316666220302115901.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias